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ABSTRACT: Background. Metastasis in a tracheostomy site occurs
rarely, usually from head and neck primary tumors. Breast
cancer relapse to a tracheostomy has not been described to
date.
Methods and Results. A 71-year-old women presented with symptoms
typical of central airway obstruction, 10 years after mastectomy for
breast cancer. Fifteen months before admission, when cancer follow-
up was negative, she also had surgery for cerebral aneurysm and a
tracheostomy. On admission, CT showed a solid mass infiltrating the
tracheostomy tract and projecting into the airway. Tracheal
obstruction palliation was achieved by laser resection of the
endotracheal growth and stenting. Histology documented breast
cancer metastasis.
Conclusions. Tracheostomy site metastasis was the presenting sign of
late-onset relapse of breast cancer. This case supports the concept of
surgery-driven interruption of micrometastatic cancer dormancy, in that
the initial recurrence developed in a tracheostomy that was surgically
created several years after resection of the primary tumor.VC 2013 Wiley
Periodicals, Inc. Head Neck 35: E359–E362, 2013
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INTRODUCTION
Relapse of head and neck cancer at a tracheostomy site is
unusual but well documented.1–3 The mechanisms that
have been proposed to explain such recurrence include
intraoperative implantation from tumor-contaminated
instruments, and growth at the stoma site of cancer cells
disseminated by the lymphatic or hematogenous route.
Moreover, it has been postulated that local inflammation
and tissue trauma around the stoma may provide a
favorable microenvironment for the growth of dormant
metastases.4 Patients with breast cancer, the most frequent
malignant tumor among females, are at risk of developing
metastases ubiquitously during their entire lifetime.5 To
our knowledge, however, metastasis of cancer of the breast
to a tracheostomy has not been described previously.
CASE REPORT
A 71-year-old woman was admitted to our hospital as
an emergency for acute respiratory failure on January 6,
2010. The patient reported nonproductive cough for
several weeks, hemoptysis and progressive dyspnea in the
previous days. She had signs of central airway obstruction
with tirage and cyanosis, and her peripheral blood O2
saturation was 86% in room air. Inspection of her neck
revealed a tracheostomy scar with reddened skin, under
which a 3-cm solid mass extending deeply in the neck
was palpable. The patient had a history of cancer of the
right breast, diagnosed in 2000. This lesion was invasive
ductal carcinoma positive for progesterone and estrogen
receptors and negative for human epidermal growth factor
receptor 2. The tumor was 25 mm in diameter, stage pT2,
pN1b, G2. The serum level of CA 15-3 was 38.6 U/mL
(normal range, 0–30 U/mL). Treatment was effected with
radical mastectomy, followed by chemotherapy (6 cycles
of cyclophosphamide, methotrexate, and fluorouracil),
radiotherapy (50 Gy), and 5-year tamoxifen. Semiannual
follow-up was then carried out regularly, with negative
findings. In September 2008 the patient developed a rup-
tured cerebral aneurysm that required surgical clipping
and cerebral decompression. She also needed a tracheos-
tomy that was made without encountering any tissue
abnormalities in the neck. Recovery after the neurosurgi-
cal procedure was satisfactory, with minor neurologic def-
icit, and the tracheostomy cannula was removed after 8
months, followed by spontaneous closure of the stoma.
The patient was subsequently lost to follow-up.
On admission, approximately 15 months after the cere-
brovascular accident, staging with showed a 3-  4-cm
solid growth in the soft tissues of the neck above the ster-
nal notch that infiltrated the tracheotomy tract. This
growth projected into the tracheal lumen 3 cm below the
vocal cords, severely obstructing the airway (5 mm free
space) (Figures 1A–C). Moreover, CT demonstrated a sin-
gle 1.8-cm nodule in the right upper lung lobe, suspicious
for malignancy (Figure 2). There was no other evidence of
metastases elsewhere. Tracheo-bronchoscopy confirmed
approximately 90% obstruction of the airway, caused by a
2.5-cm solid mass growing from the second and third
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tracheal rings into the lumen (Figure 3A). The bulk of the
endotracheal growth was removed with diode laser
through the rigid bronchoscope, and clearance of the air-
way was obtained (Figure 3B). Histology of the excised
endotracheal growth revealed invasive ductal carcinoma of
the breast with positivity for progesterone and estrogen
receptors (Figures 4A and 4B), with an immunohisto-
chemical pattern mirroring that of the primary cancer
resected 10 years earlier (Figures 4B and 4C). Needle bi-
opsy of the right lung nodule also showed the same im-
munohistochemical features of breast cancer metastasis.
The serum CA 15-3 level was normal (20.8 U/mL). After
laser ablation of the endotracheal mass, a silicone 12-mm
tracheal stent was positioned (Dumon; Novatech, La Cio-
tat, France). Therapy with aromatase inhibitor (Exemes-
tane) was instituted, but the patient did not respond and
died with disseminated metastases on June 26, 2010,
approximately 6 months after diagnosis of breast cancer
relapse.
DISCUSSION
Breast cancer metastases frequently localize in the
lower respiratory tract,6,7 whereas tracheal involvement is
uncommon and usually characterized by compression/
infiltration from adjacent pulmonary or paratracheal
lymph node metastases.8 Direct metastases of breast can-
cer to the trachea are exceedingly rare; a search of the lit-
erature revealed that only 3 such cases have been
reported.9,10 The rarity of the case presented here may be
explained by the scarce propensity of breast cancer to
relapse at tracheal level, in addition to the fact that
patients with exceptional cases of breast cancer need a
tracheostomy. An increased level of CA 15-3 is often
associated with metastatic breast carcinoma,11 but in our
patient the serum level of this marker was normal when
recurrence was diagnosed. Evidence of endotracheal me-
tastasis of breast cancer at the tracheostomy was the first
indication of relapsed disease, 10 years after resection
of the primary tumor. Notably, the latter was estrogen
receptor–positive, a feature associated with greater hazard
of recurrence from years 5 to 12.12 Breast cancer relapse
more than 10 years after apparently radical resection of
the primary lesion is a well-documented event.13,14 A
possible mechanism for late recurrence of breast cancer is
the reactivation of fully malignant tumor cells seeded
before or at the time of primary tumor resection that
remained "dormant" for many years.4,15 In addition, it has
been shown that wounds are a favorable microenviron-
ment for tumor growth and that local tissue trauma and
inflammation contribute to tumorigenesis and malignant
disease progression.4,15,16 It is noteworthy that in our
patient the tracheostomy was made without encountering
any abnormalities in the anterior neck tissues, thus ruling
out a preexisting clinically detectable relapse. Therefore,
we hypothesize that the surgical procedures performed in
September 2008 (clipping of aneurysm and tracheostomy)
facilitated the outgrowth of otherwise dormant circulating
cancer cells at the tracheostomy, a site characterized by
inflammation and granulation caused by the tracheal
FIGURE 1. CT axial (A) and coronal (B) views showing a solid mass (arrows) infiltrating the soft tissues of the anterior aspect of the neck, and the
trachea. CT sagittal view (C) shows the neoplastic growth that extends from the cutaneous scar of the tracheostomy to the tracheal wall and
invades the airway. The latter is subtotally obstructed by the solid growth (arrows).
FIGURE 2. CT scan showing a 1.8-cm peripheral nodule with
spiculated margins in the right upper lobe of the lung.
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cannula. Fifteen months elapsed from tracheostomy
placement and symptomatic diagnosis of the 3-  4-cm
recurrent growth at the stoma site, a time interval that
may seem exceedingly short for such a large recurrence
to develop. However, in agreement with the short volume
doubling time of breast cancer recurrences, reported to
range between 25 and 51 days,17,18 we estimated that a
micrometastasis growing up to 4 cm in diameter in 15
months would have a volume doubling time of about 30
days. Interestingly, a review of percutaneous endoscopic
FIGURE 3. Endoscopic view of neoplastic growth bulging into the airway from the anterior aspect of the tracheal wall (A), at the second to third
ring level (arrow). Clearance of the airway was achieved after removal of the neoplastic growth with the diode laser. Tip of laser probe indicated by
arrows (B). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Histological features of the endotracheal growth showing metastasis of breast carcinoma (A, B). Proliferation in the subepithelial layer
of tumor cells with eosinophilic cytoplasm, and nuclei with evident nucleoli arranged in cords and trabeculae with zonal glandular differentiation
(A, hematoxylin-eosin stain, original magnification 200). Tumor cells express estrogen receptors (ER) at the nuclear level (B, original
magnification400). These morphologic and immunohistochemical features largely overlap those of the primary breast carcinoma resected 10
years before, shown in (C) (hematoxylin-eosin stain, original magnification 400) and in D (ER expression, original magnification 400). [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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gastrostomy (PEG)–associated metastases from head and
neck tumors reported that stomal recurrence became clini-
cally evident at a mean of 8 months (range, 2–24 months)
after PEG placement.19
In our patient, persistent cough was long misinterpreted
as chronic bronchitis, and the diagnosis of tracheal metas-
tasis was delayed until the occurrence of acute respiratory
failure with tirage, when the airway lumen was nearly
occluded. When the disease is multimetastatic, as in our
case, treatment is symptom palliation, associated with
chemotherapy and hormone therapy, if feasible.10,20 Laser
resection of endotracheal metastasis and stent placement
are recommended to obtain tracheal canalization when
acute respiratory failure occurs. These endoscopic proce-
dures may improve the quality of life and prolong sur-
vival for a brief period. Regardless of the primary tumor
histology and the type of treatment, however, the pres-
ence of tracheal metastasis from distant malignancies
points to widespread disease and dismal prognosis, with
survival ranging from a few months to 2 years.10,20,21
One of the 3 published cases of breast cancer recurrence
to the trachea survived 8 months, and no information is
available on the survival period of the other 2.9,10
CONCLUSIONS
Late-onset metastasis of breast cancer is often associated
with disseminated disease. In the case presented, tracheal
obstruction was the initial sign of late recurrence in a tra-
cheostomy, a distant site of breast cancer relapse that has
not been described to date. Moreover, this case supports
the concept of surgery-driven interruption of circulating
breast cancer cell dormancy, given that the initial and larg-
est recurrence developed in a tracheostomy that was surgi-
cally created 8.5 years after removal of the primary tumor.
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